Mersana Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRSN and other ETFs, options, and stocks.About MRSN
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592.
CEOMartin H. Huber
CEOMartin H. Huber
Employees102
Employees102
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2001
Founded2001
Employees102
Employees102
MRSN Key Statistics
Market cap137.32M
Market cap137.32M
Price-Earnings ratio-1.95
Price-Earnings ratio-1.95
Dividend yield—
Dividend yield—
Average volume67.32K
Average volume67.32K
High today$28.36
High today$28.36
Low today$27.31
Low today$27.31
Open price$27.90
Open price$27.90
Volume70.12K
Volume70.12K
52 Week high$70.73
52 Week high$70.73
52 Week low$5.21
52 Week low$5.21
Stock Snapshot
The current Mersana Therapeutics(MRSN) stock price is $27.47, with a market capitalization of 137.32M. The stock trades at a price-to-earnings (P/E) ratio of -1.95.
During the trading session on 2025-12-04, Mersana Therapeutics(MRSN) shares reached a daily high of $28.36 and a low of $27.31. At a current price of $27.47, the stock is +0.6% higher than the low and still -3.1% under the high.
Trading volume for Mersana Therapeutics(MRSN) stock has reached 70.12K, versus its average volume of 67.32K.
The stock's 52-week range extends from a low of $5.21 to a high of $70.73.
The stock's 52-week range extends from a low of $5.21 to a high of $70.73.
Analyst ratings
100%
of 8 ratingsBuy
0%
Hold
100%
Sell
0%
People also own
Based on the portfolios of people who own MRSN. This list is generated using Robinhood data, and it’s not a recommendation.